Search for: "GlaxoSmithKline LLC" Results 1 - 20 of 177
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 Feb 2022, 9:03 pm by Patent Docs
Federal Circuit Denies En Banc Review in GlaxoSmithKline LLC v. [read post]
25 Jun 2017, 9:25 pm by Patent Docs
District Court Overrules Defendants' Objections to Magistrate's Report on Lost Profits By Donald Zuhn -- Earlier this month, in GlaxoSmithKline LLC v. [read post]
17 Apr 2013, 9:59 pm by Patent Docs
GlaxoSmithKline LLC, the Federal Circuit affirmed the determination by the District Court for the Southern District of California that the claim term "anti-CD20 antibody" as used in U.S. [read post]
26 Feb 2014, 9:59 pm by Patent Docs
Noonan -- The Federal Circuit issued an opinion on Monday in GlaxoSmithKline LLC v. [read post]
2 Jul 2012, 10:02 am by Mike Scarcella
A team from Covington & Burling in Washington represented the pharmaceutical giant GlaxoSmithKline LLC in a record-setting $3 billion criminal and civil settlement over drug misbranding. [read post]
2 Jul 2012, 10:02 am by Mike Scarcella
A team from Covington & Burling in Washington represented the pharmaceutical giant GlaxoSmithKline LLC in a record-setting $3 billion criminal and civil settlement over drug misbranding. [read post]
2 Jul 2012, 10:02 am by Mike Scarcella
A team from Covington & Burling in Washington represented the pharmaceutical giant GlaxoSmithKline LLC in a record-setting $3 billion criminal and civil settlement over drug misbranding. [read post]
3 Jul 2012, 9:11 am
GlaxoSmithKline LLC ("Glaxo") has agreed to settle criminal and civil charges, including 4 separate whistleblower suits, related to several different prescription medications for a total of $3 billion. [read post]
16 Dec 2011, 2:39 pm by mikedavidson
., a subsidiary of drug manufacturing giant GlaxoSmithKline, has pled guilty to charges of manufacturing defective drugs. [read post]
15 May 2023, 8:13 am by Patent Docs
GlaxoSmithKline LLC, and in some ways the only positive outcome is that the Court has shown it is willing to refuse to take action is cases other than subject matter eligibility (although Justice Kavanaugh indicated he would have granted the petition). [read post]
5 Jul 2012, 5:56 pm
GlaxoSmithKline LLC has agreed to pay $3B to settle civil and criminal allegations that it illegally promoted certain prescription medications, engaged in false price reporting practices, and failed to report certain safety information. [read post]
27 Jul 2014, 9:38 pm by Patent Docs
GlaxoSmithKline LLC et al. v. [read post]
2 Jul 2012, 9:42 pm by A. Brian Albritton
Department of Justice announced today that "global health care giant" GlaxoSmithKline LLC ("GSK") agreed to plead guilty and to pay $3 billion to resolve "its criminal and civil liability arising from the company’s unlawful promotion of certain prescription drugs, its failure to report certain safety data, and its civil liability for alleged false price reporting practices. [read post]